deflazacort has been researched along with fentanyl in 2 studies
| Studies (deflazacort) | Trials (deflazacort) | Recent Studies (post-2010) (deflazacort) | Studies (fentanyl) | Trials (fentanyl) | Recent Studies (post-2010) (fentanyl) |
|---|---|---|---|---|---|
| 452 | 99 | 115 | 15,288 | 4,310 | 4,483 |
| Protein | Taxonomy | deflazacort (IC50) | fentanyl (IC50) |
|---|---|---|---|
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 6.5 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.6342 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0122 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.1888 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0122 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.0058 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.3092 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 5.893 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 1.58 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0031 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.8197 | |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | 4.973 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.354 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Adame, M; Calderón, R; Fernández-Liesa, JI; Mendieta, JM; Muñoz, C; Panadero, A | 1 |
2 other study(ies) available for deflazacort and fentanyl
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
[Common variable immunodeficiency associated with autoimmune thrombocytopenia: anesthetic management].
Topics: Adjuvants, Anesthesia; Adult; Aminocaproic Acid; Androstanols; Anesthesia, Inhalation; Anesthetics; Atropine; Autoimmune Diseases; Bromazepam; Combined Modality Therapy; Common Variable Immunodeficiency; Fentanyl; Fissure in Ano; Granulocyte Colony-Stimulating Factor; Hemorrhoids; Humans; Hypnotics and Sedatives; Immunoglobulins, Intravenous; Laryngeal Masks; Male; Methyl Ethers; Nitrous Oxide; Platelet Transfusion; Postoperative Complications; Preanesthetic Medication; Pregnenediones; Propofol; Purpura, Thrombocytopenic, Idiopathic; Ranitidine; Rocuronium; Sevoflurane; Thrombocytopenia | 1998 |